Enclear Therapies, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with serious diseases. The company specializes in harnessing the power of the immune system to create treatments that address unmet medical needs. With a commitment to scientific excellence and patient-centric approaches, Enclear aims to transform the landscape of therapeutic options available for challenging health conditions. Their pipeline includes novel candidates that leverage advanced technologies and research to improve patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#4 in Newburyport, MA

#2,098 in Massachusetts

#35,924 in US

Newburyport, MA, United States of America

Enclear Therapies, Inc.

Forward Citations = 3

14 inventors:

Kevin Kalish (6 out of 6 patents)

Gianna N Riccardi (6 out of 6 patents)

Marcie Ann Glicksman (6 out of 6 patents)

4. Anthony DePasqua (5 out of 7 patents)

5. William X Siopes (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Enclear Therapies, Inc.. Retrieved from https://idiyas.com/company/enclear-therapies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]